Advertisement
U.S. markets close in 34 minutes
  • S&P 500

    5,263.64
    +15.15 (+0.29%)
     
  • Dow 30

    39,857.97
    +97.89 (+0.25%)
     
  • Nasdaq

    16,405.53
    +6.01 (+0.04%)
     
  • Russell 2000

    2,124.18
    +9.83 (+0.46%)
     
  • Crude Oil

    83.09
    +1.74 (+2.14%)
     
  • Gold

    2,241.90
    +29.20 (+1.32%)
     
  • Silver

    24.97
    +0.22 (+0.88%)
     
  • EUR/USD

    1.0790
    -0.0040 (-0.37%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2622
    -0.0016 (-0.12%)
     
  • USD/JPY

    151.3970
    +0.1510 (+0.10%)
     
  • Bitcoin USD

    70,737.27
    +1,974.52 (+2.87%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Ligand shares should be bought on weakness, says Roth Capital

Roth Capital believes that Ligand's risk is mitigated by the 85 products in its pipeline. The firm thinks that the company's business model remains strong.

Advertisement